Source:http://linkedlifedata.com/resource/pubmed/id/15564152
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2004-11-26
|
pubmed:abstractText |
2-Deoxy-2-[18F]fluoro-D-Glucose positron emission tomography (FDG-PET) stages patients with Hodgkin's disease (HD) and Non-Hodgkin's lymphoma (NHL) with higher accuracy than computed tomography (CT). We sought to determine whether integrated (hardware) fused PET/CT imaging results in further improvements in staging accuracy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1536-1632
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
411-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15564152-Female,
pubmed-meshheading:15564152-Fluorodeoxyglucose F18,
pubmed-meshheading:15564152-Hodgkin Disease,
pubmed-meshheading:15564152-Humans,
pubmed-meshheading:15564152-Lymphoma,
pubmed-meshheading:15564152-Male,
pubmed-meshheading:15564152-Middle Aged,
pubmed-meshheading:15564152-Neoplasm Staging,
pubmed-meshheading:15564152-Positron-Emission Tomography,
pubmed-meshheading:15564152-Sensitivity and Specificity,
pubmed-meshheading:15564152-Tomography, X-Ray Computed
|
pubmed:articleTitle |
Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma.
|
pubmed:affiliation |
Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center, UCLA David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6942 USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|